Jean-David B.
- Country
- France
- Department
- Dermatology
Research Overview
- A Prospective Multicenter Randomized Placebo-Controlled Study of Upadacitinib in Adults with Erosive Mucosal Lichen Planus and Lichen Planopilaris
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Enpatoran for Active Cutaneous Lupus Erythematosus (with or without systemic disease)
- INCB 18424-320: A phase 3, double-blind, randomised, vehicle-controlled, efficacy and safety study of ruxolitinib cream in participants with Prurigo Nodularis. Topical ruxolitinib evaluation in Prurigo Nodularis (TRuE-PN2)
Data & Insights
Has run more than one trial at 296 of 497 partner sites.
Specializations
Autoimmune Skin Conditions
Specialized in treating complex cutaneous lupus erythematosus variants, including both subacute and chronic forms. Active research into novel therapeutic approaches for bullous pemphigoid and mucous membrane pemphigoid.
- Cutaneous Lupus Management
- Pemphigoid Disorders
- Dermatomyositis Treatment
Inflammatory Dermatoses
Expert focus on managing atopic dermatitis across various severity levels, with particular attention to moderate-to-severe cases. Investigates innovative treatments for prurigo nodularis and pyoderma gangrenosum.
- Atopic Dermatitis Therapeutics
- Prurigo Nodularis Management
- Ulcerative Skin Conditions
Specialized Dermatological Conditions
Dedicated research in treating cutaneous sarcoidosis with facial involvement and management of pemphigus variants. Expertise in both established and emerging therapeutic approaches.
- Facial Sarcoidosis Treatment
- Pemphigus Management
- Novel Therapeutic Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.